Yahoo Finance15d
Anagram Therapeutics Selects Epicured as Nutrition Partner On Successful Cystic Fibrosis and Exocrine Pancreatic Insufficiency Dosing Study
Anagram Therapeutics is a client of Epicured's Life Sciences Division dedicated to advancing scientific research through thoughtful integration of nutrition in study protocols. Epicured ...
Longview News-Journal15d
Anagram Therapeutics Selects Epicured as Nutrition Partner On Successful Cystic Fibrosis and Exocrine Pancreatic Insufficiency Dosing Study
Anagram Therapeutics is a client of Epicured's Life Sciences Division dedicated to advancing scientific research through thoughtful integration of nutrition in study protocols. Participants in ...
Yahoo Finance15d
Anagram Therapeutics Selects Epicured as Nutrition Partner On Successful Cystic Fibrosis and Exocrine Pancreatic Insufficiency Dosing Study
Anagram Therapeutics is a client of Epicured's Life Sciences Division dedicated to advancing scientific research through thoughtful integration of nutrition in study protocols. Epicured, Inc.
VentureBeat29d
The U.S. unicorns most likely to go public in 2025 | NVCA/PitchBook
Learn More There are a raft of U.S. unicorns — those valued at $1 billion or more — that are likely to go public in 2025, according to the PitchBook/NVCA Venture Monitor for the fourth quarter ...
Crain's New York28d
Five New York-based firms that could see successful IPOs
As for which unicorns are likely to succeed when they do, PitchBook has some ideas. The research firm released its latest quarterly report on venture activity Tuesday. In it is a list of 27 ...